FDA clears Apollo Endosurgery's SuMO endoscopic tissue access and resection system
The FDA cleared Apollo Endosurgery's SuMO endoscopic tissue access and resection system, which allows surgeons to remove large, flat precancerous gastrointestinal lesions and polyps during endoscopy procedures without leaving scars, according to a news release.
The global gastrointestinal endoscopes market is expected to reach $2.7 billion in 2017, according to a ``Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017'' report.